# Stephenson Cancer Center, OU Health

Source: https://onco.cc/institutions/stephenson-oklahoma/  
OnCo record `stephenson-oklahoma` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Oklahoma's only NCI-designated centre, consistently among the top enrollers in NRG gynaecologic trials and home of the SOLO1 and MIRASOL ovarian cancer lead investigator.

## Summary

NCI-designated in 2018, Stephenson Cancer Center is the only NCI centre in Oklahoma and serves a state with large American Indian populations. Its gynaecologic oncology group is one of the most productive in the NCI's National Clinical Trials Network: Kathleen Moore led SOLO1, which established olaparib maintenance in newly diagnosed BRCA-mutated ovarian cancer, and MIRASOL, which confirmed the folate receptor alpha ADC mirvetuximab soravtansine in platinum-resistant disease. The Oklahoma Tobacco Research Center and TSET-funded cancer control programmes address the state's high smoking rates, and the centre runs an active phase 1 programme.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- City: Oklahoma City, OK, US
- Type: cancer-center
- NCI designation: clinical
- Website: https://www.ouhealth.com/stephenson-cancer-center/

## Sources

- Stephenson Cancer Center: https://www.ouhealth.com/stephenson-cancer-center/
- Clinical trials: https://www.ouhealth.com/stephenson-cancer-center/research-clinical-trials/

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/), [Endometrial cancer](https://onco.cc/cancers/endometrial/), [Ovarian cancer](https://onco.cc/cancers/ovarian/)
- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/), [PARP inhibitors](https://onco.cc/technologies/parp-inhibitor/)
- targets: [Folate receptor alpha](https://onco.cc/targets/folr1/), [PARP](https://onco.cc/targets/parp/)
- drugs: [Mirvetuximab soravtansine](https://onco.cc/drugs/mirvetuximab-soravtansine/), [Olaparib](https://onco.cc/drugs/olaparib/)
- companies: [NRG Oncology](https://onco.cc/companies/nrg-oncology/)
- people: [Kathleen N. Moore](https://onco.cc/people/kathleen-moore/)
- bottlenecks: [Trials do not represent the people who get cancer](https://onco.cc/bottlenecks/b-trial-diversity/)
- institutions: [National Cancer Institute (NIH)](https://onco.cc/institutions/nci/)

---
JSON: https://onco.cc/api/v1/entities/stephenson-oklahoma.json